INSIDER · CIK 1862109
venBio Global Strategic Fund IV, L.P.
10% Owner at Attovia Therapeutics, Inc. (ATTO)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$6.5MBought on the market
$0.00Sold on the market
1Companies
Aug 10, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 202616:12 | Aug 6, 2026 | ATTOAttovia Therapeutics, Inc. | 10% Owner | P · Buy | $17.00 | +382,352 | 4,181,367 | +10% | +$6.5M | -22.4% | -10.2% |
| Aug 10, 202616:12 | Aug 6, 2026 | ATTOAttovia Therapeutics, Inc. | 10% Owner | C · Convert | — | +3,799,015 | 3,799,015 | New | — |